Project Grant R01NR021347
- Federal Grant Award Summary The Medical University of South Carolina received a $188,568 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective April 1, 2026 through March 31, 2031. This award supports a five-year research initiative investigating regional disparities in skeletal muscle microvascular dysfunction (MVD) in systolic heart failure patients. The research addresses the gap in understanding...
- Federal Project Grant Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Medical University of South Carolina a Project Grant of $711,060 on August 20, 2025, under the Cardiovascular Diseases Research program (CFDA 93.837) to develop and test the feasibility and acceptability of "SUPPORT-T," a mobile application designed to increase access to palliative care for patients with progressive pulmonary fibrosis (PPF) and their caregivers. The project, which extends...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $630,139 Project Grant award from the National Institutes of Health Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective August 1, 2025, through May 31, 2030. The award funds the ENHANCE-TTS (Engaging Pharmacists to Advance Tobacco Treatment Service Delivery) program, which develops and implements tobacco treatment specialist training for clinical pharmacists serving...
- Federal Project Grant Award Summary The Medical University of South Carolina (MUSC) received a Project Grant award of $247,600 from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective February 16, 2026, with completion targeted for January 31, 2029. The award supports research investigating epigenetic regulation mechanisms underlying calcific aortic valve disease (CAVD), a condition affecting approximately 3% of...
- Federal Project Grant Award Summary The University of Massachusetts Medical School received a $167,398 project grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective July 1, 2025, through June 30, 2030. The award funds the development and evaluation of the Paramedic Evaluation for Acute COPD Exacerbation (PEACE) intervention, a Mobile Integrated Healthcare (MIH) program that deploys community paramedics...
- Federal Project Grant Award Summary The Medical University of South Carolina received a $210,013 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with a completion date of August 31, 2029. This grant supports a pilot randomized controlled trial testing the REACH for Equity in Pediatric Obstructive Sleep Evaluation (REPOSE) navigation intervention, a multilevel, theory-based...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded The Johns Hopkins University a $1.51 million Project Grant (CFDA 93.837: Cardiovascular Diseases Research) effective May 1, 2025, through February 28, 2029, to conduct research on the role of cofilin-1 in mitochondrial quality control and airway epithelial dysfunction in chronic bronchitis and chronic obstructive pulmonary disease (COPD). The research addresses a significant public health burden, as COPD...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded the University of Virginia a $1.38M Project Grant (CFDA 93.837 – Cardiovascular Diseases Research) effective May 1, 2025, through February 28, 2030, to conduct research on post-transcriptional regulatory networks in chronic obstructive pulmonary disease (COPD). The project will generate RNA binding protein (RBP) regulatory networks by developing methods to identify RBP-to-isoform interactions, integrating...
- Federal Project Grant Award Summary The National Institute of Nursing Research (NINR), under the Nursing Research program (CFDA 93.361), awarded a $3.48M project grant to the University of Massachusetts Medical School on April 16, 2026, with completion scheduled for March 31, 2030. This research project examines the effectiveness of school-based health centers (SBHCs) in improving pediatric asthma care outcomes, with particular emphasis on health equity for low-income and marginalized...
- Federal Project Grant Award Summary The Medical University of South Carolina (MUSC) received a $215,976 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), effective March 26, 2026, with a completion date of February 28, 2030. The DATA ANALYTICS TRAINING AND PROFESSIONAL DEVELOPMENT (DATA-PRO) FOR BEHAVIORAL AND SOCIAL SCIENCES RESEARCH program delivers structured e-learning modules and advanced...
The Medical University of South Carolina received a $1.78M Project Grant from the National Institute of Nursing Research (CFDA 93.361 – Nursing Research) awarded March 25, 2026, with a completion date of February 28, 2030. Under the RESP-FIT (Respiratory Muscle Strength Training and Fitness Program) initiative, the institution will conduct a randomized controlled trial (RCT) evaluating the efficacy of a multicomponent, mobile health (mHealth)-delivered chronic obstructive pulmonary disease (COPD) intervention for rural populations. The research will assess respiratory muscle strength training (RMST) effectiveness on dyspnea, dyspnea-related kinesiophobia, and respiratory quality of life outcomes in adults with COPD. The intervention combines home-based RMST utilizing a portable training device, mHealth technology, behavioral theory, remote spirometry, and ecological momentary assessment (EMA) to enable real-time measurement of lung function and symptoms in remote settings. This integrated delivery approach addresses three primary areas: COPD-related physical deconditioning and symptoms, health behaviors including kinesiophobia, and accessibility for rural communities. The project will also identify barriers, facilitators, and contextual factors influencing intervention implementation, providing an empirically validated, accessible respiratory intervention designed to address the disproportionate burden of COPD in rural areas.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.8m | 4/2/26 |